X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4017) 4017
Publication (58) 58
Book Chapter (25) 25
Dissertation (11) 11
Book / eBook (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
preserved ejection fraction (2747) 2747
cardiac & cardiovascular systems (2443) 2443
humans (2310) 2310
heart failure (2140) 2140
male (1363) 1363
female (1316) 1316
heart failure with preserved ejection fraction (1092) 1092
aged (1063) 1063
heart failure - physiopathology (948) 948
middle aged (870) 870
echocardiography (841) 841
mortality (825) 825
prognosis (736) 736
heart-failure (722) 722
hypertension (597) 597
stroke volume (585) 585
risk factors (579) 579
diagnosis (546) 546
cardiovascular (525) 525
dysfunction (514) 514
diastolic dysfunction (511) 511
cardiology (443) 443
stroke volume - physiology (434) 434
heart failure - diagnosis (430) 430
aged, 80 and over (421) 421
prevalence (414) 414
abridged index medicus (411) 411
heart (411) 411
heart diseases (379) 379
outcomes (371) 371
analysis (361) 361
cardiac patients (355) 355
heart failure - drug therapy (348) 348
animals (347) 347
peripheral vascular disease (347) 347
association (335) 335
exercise (334) 334
care and treatment (329) 329
prospective studies (311) 311
heart failure - mortality (303) 303
treatment outcome (300) 300
cardiovascular disease (285) 285
diastolic function (282) 282
heart failure - therapy (281) 281
ejection fraction (269) 269
exercise capacity (269) 269
pulmonary hypertension (269) 269
blood pressure (266) 266
diastole (263) 263
ventricular dysfunction, left - physiopathology (260) 260
risk (259) 259
ventricular function, left (258) 258
heart failure - epidemiology (254) 254
adult (253) 253
medicine, general & internal (252) 252
hemodynamics (251) 251
disease (247) 247
medicine & public health (243) 243
follow-up studies (239) 239
systolic function (229) 229
research (227) 227
epidemiology (225) 225
management (216) 216
guidelines (213) 213
health aspects (211) 211
hospitalization (211) 211
patients (210) 210
european-society (206) 206
myocardial-infarction (204) 204
retrospective studies (202) 202
ventricular function, left - physiology (201) 201
internal medicine (198) 198
heart failure - complications (197) 197
fibrosis (195) 195
survival (193) 193
diabetes (190) 190
recommendations (189) 189
comorbidity (187) 187
population (186) 186
physiology (185) 185
time factors (185) 185
biomarkers (182) 182
ventricle (180) 180
double-blind (177) 177
biomarkers - blood (173) 173
left-ventricular dysfunction (172) 172
heart failure - diagnostic imaging (168) 168
atrial fibrillation (167) 167
natriuretic peptide (167) 167
heart failure - blood (166) 166
natriuretic peptides (166) 166
predictive value of tests (166) 166
prognostic value (164) 164
cardiovascular diseases (163) 163
task-force (162) 162
trial (162) 162
community (160) 160
spironolactone (160) 160
pharmacology & pharmacy (158) 158
medical research (157) 157
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3958) 3958
German (48) 48
Russian (47) 47
Spanish (35) 35
Portuguese (16) 16
Japanese (15) 15
French (14) 14
Czech (9) 9
Polish (4) 4
Turkish (3) 3
Korean (2) 2
Slovak (2) 2
Chinese (1) 1
Hungarian (1) 1
Icelandic (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 12/2014, Volume 130, Issue 25, pp. 2310 - 2320
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2010, Volume 55, Issue 6, pp. 526 - 537
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 10/2017, Volume 10, Issue 10, pp. 1211 - 1221
...) stratify clinical phenotypes and outcome in heart failure preserved ejection fraction (HFpEF) patients. Background Pulmonary hypertension and RV dysfunction are key hemodynamic abnormalities in HFpEF... 
heart failure with preserved ejection fraction | right ventricle | pulmonary hypertension | hemodynamics | CARDIAC & CARDIOVASCULAR SYSTEMS | ASSOCIATIONS | CARDIOLOGY | PLANE SYSTOLIC EXCURSION | EUROPEAN-SOCIETY | COMMUNITY | RECOMMENDATIONS | RIGHT-VENTRICULAR FUNCTION | ECHOCARDIOGRAPHY | DYSFUNCTION | HYPERTENSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Hypertension, Pulmonary - diagnosis | Prevalence | Prognosis | Prospective Studies | Humans | Middle Aged | Heart Failure - physiopathology | Ventricular Dysfunction, Right - epidemiology | Hypertension, Pulmonary - physiopathology | Male | Cardiac Catheterization | Arterial Pressure | Echocardiography, Doppler | Aged, 80 and over | Female | Ventricular Dysfunction, Right - physiopathology | Heart Failure - diagnosis | Chicago - epidemiology | Heart Failure - epidemiology | Myocardial Contraction | Severity of Illness Index | Reproducibility of Results | Comorbidity | Risk Factors | Pulmonary Artery - physiopathology | Hypertension, Pulmonary - epidemiology | Ventricular Dysfunction, Right - diagnosis | Pulmonary Circulation | Stroke Volume | Phenotype | Italy - epidemiology | Aged | Ventricular Function, Right | Heart failure | Atrial fibrillation | Patient outcomes | Risk factors | Pulmonary hypertension
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 11/2012, Volume 5, Issue 6, pp. 710 - 719
Journal Article
European heart journal, ISSN 1522-9645, 2010, Volume 32, Issue 6, pp. 670 - 679
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2015, Volume 132, Issue 5, pp. 402 - 414
...) with preserved ejection fraction (HFpEF), but its prognostic relevance is not known. We determined whether left ventricular longitudinal strain (LS... 
clinical trial | strain | heart failure | heart ventricles | spironolactone | preserved left ventricular function | CARDIAC-FUNCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | TOPCAT TRIAL | ALDOSTERONE ANTAGONIST TRIAL | MYOCARDIAL DEFORMATION | RANDOMIZED CONTROLLED-TRIAL | EUROPEAN-SOCIETY | DIASTOLIC DYSFUNCTION | SOCIETY-OF-CARDIOLOGY | SPECKLE TRACKING ECHOCARDIOGRAPHY | PERIPHERAL VASCULAR DISEASE | AMERICAN-SOCIETY | Prognosis | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Ventricular Dysfunction, Left - mortality | Incidence | Spironolactone - pharmacology | Mineralocorticoid Receptor Antagonists - pharmacology | Aged, 80 and over | Electrocardiography | Female | Spironolactone - therapeutic use | Double-Blind Method | Heart Failure, Systolic - drug therapy | Heart Failure, Systolic - mortality | Heart Arrest - epidemiology | Stroke Volume - physiology | Stroke Volume - drug effects | Survival Rate | Treatment Outcome | Ventricular Dysfunction, Left - physiopathology | Mineralocorticoid Receptor Antagonists - therapeutic use | Ventricular Dysfunction, Left - drug therapy | Internationality | Heart Failure, Systolic - physiopathology | Aged | Heart failure | Usage | Echocardiography | Research | Heart ventricles | Risk factors | Heart failure with preserved ejection fraction | systolic function | clinical trials | echocardiography
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2009, Volume 53, Issue 23, pp. 2150 - 2158
Journal Article